Target: HSP22.
Conjugate: RPE .
Product Type: Polyclonal.
Immunogen: Human HSP22.
Swiss-Prot: Q9UJY1.
Purification: Peptide Affinity Purified.
Storage Buffer: PBS pH7.4, 50% glycerol, 0.09% sodium azide.
Concentration: 1 mg/ml.
Specificity: Detects ~22kDa. Does not cross-react with HSP27 or alpha-crystallin.
Cellular Localization: Cytoplasm, Nucleus.
Scientific Background: HSP22 (HSPB8) is a 196-amino acid protein that is a member of the small heat shock protein super-family and the human protein is most closely related to HSP27. Similar to most other sHSPs, HSP22 is predominately transcribed in skeletal muscle and heart, as well as the placenta (1). HSP22 is a monomeric protein which interacts with HSPB1. It displays temperature-dependent chaperone activity. In a two hybrid screen, HSPB8 interacted preferentially with a triple aspartate form of HSP27 which mimics HSP27 phosphorylated at Ser15, Ser78, and Ser82, as compared to wild-type HSP27 (2). HSPB8 has two binding domains (N and C Terminal) that are specific for different binding partners, and has the ability to bind itself and other sHSPs (3). The chaperone-like activity is of great importance to the function of HSP22 in various processes including proliferation, apoptosis and macro autophagy (4). Mutations in the HSPB8 gene are associated with the inherited peripheral neuropathies, autosomal dominant distal hereditary motor neuropathy type IIA (dSMA) and axonal Charcot-Marie-Tooth disease type 2L (CMT2L) (5).
References: 1. Kappe G., et al. (2001) Biochem Biophys Acta. 1520: 1-6.2. Benndorf R., et al. (2001) J Biol Chem. 276: 26753-26761.3. Sun X., et al. (2004) J Biol Chem. 279: 2394-2402.4. Kim M.V., et al. (2004) Biochem Biophys Res Commun. 325: 649-652.5. Wilhelmus M.M., et al. (2006) Acta Neuropathol. (Berl) 111: 139-149.
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
English
Deutsch
